Successful management plan of COVID-19 in a pediatric hemato-oncology department: a single-centre experience.

data collection epidemiology health services research

Journal

BMJ paediatrics open
ISSN: 2399-9772
Titre abrégé: BMJ Paediatr Open
Pays: England
ID NLM: 101715309

Informations de publication

Date de publication:
2020
Historique:
received: 05 08 2020
accepted: 03 09 2020
entrez: 30 6 2021
pubmed: 1 7 2021
medline: 1 7 2021
Statut: epublish

Résumé

COVID-19 pandemic raised concern about management of patients with paediatric cancer. We present the operating system that the Hemato-Oncology Department of the Santobono-Pausilipon Hospital applied. We divided our department in three zones: surveillance and screening; quarantine and COVID free, in order to screen admitted patients and to reduce the risk of cross infection. From 3 April until 29 May 2020 (56 days), 662 patients and caregivers underwent rapid serological tests for a total of 1397 assays. No patient or parent with SARS-CoV2 infection was found, demonstrating the effectiveness of COVID-19 screening process.

Identifiants

pubmed: 34192176
doi: 10.1136/bmjpo-2020-000818
pii: bmjpo-2020-000818
pmc: PMC7493071
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e000818

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Eur J Cancer. 2020 Jun;132:11-16
pubmed: 32305831
Pediatr Blood Cancer. 2020 Jul;67(7):e28409
pubmed: 32400924
Pediatr Blood Cancer. 2020 Aug;67(8):e28410
pubmed: 32452123
Pediatr Blood Cancer. 2020 Aug;67(8):e28466
pubmed: 32539233

Auteurs

Pio Stellato (P)

Pediatric Hemato-Oncology, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy.

Annalisa Granata (A)

Healthcare Management, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy.

Antonia De Matteo (A)

Pediatric Hemato-Oncology, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy.
Department of Translational Medical Science, Section of Pediatrics, University of Naples Federico II School of Medicine and Surgery, Naples, Italy.

Carlo Capelli (C)

Healthcare Management, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy.

Matteo Paparo (M)

Clinical Pathology Unit, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy.

Rosanna Parasole (R)

Pediatric Hemato-Oncology, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy.

Immacolata Ricciardi (I)

Clinical Pathology Unit, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy.

Francesco Paolo Tambaro (FP)

Pediatric Hemato-Oncology, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy.

Ornella Leone (O)

Clinical Pathology Unit, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy.

Lucia Quaglietta (L)

Pediatric Hemato-Oncology, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy.

Giuseppe Menna (G)

Pediatric Hemato-Oncology, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy.

Nicola Silvestri (N)

Healthcare Management, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Naples, Italy.

Classifications MeSH